REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $22,087,073 | -34.3% | 30,153,000 | -31.5% | 0.01% | -56.2% |
| Q4 2023 | $33,632,500 | -5.5% | 44,000,000 | 0.0% | 0.02% | -11.1% |
| Q3 2023 | $35,587,200 | -23.6% | 44,000,000 | 0.0% | 0.02% | -18.2% |
| Q2 2023 | $46,596,000 | -14.0% | 44,000,000 | 0.0% | 0.02% | -18.5% |
| Q1 2023 | $54,186,000 | +22.3% | 44,000,000 | -8.3% | 0.03% | +17.4% |
| Q4 2022 | $44,304,000 | -15.3% | 48,000,000 | 0.0% | 0.02% | -20.7% |
| Q3 2022 | $52,320,000 | +33.9% | 48,000,000 | 0.0% | 0.03% | +52.6% |
| Q2 2022 | $39,060,000 | -13.5% | 48,000,000 | 0.0% | 0.02% | +5.6% |
| Q1 2022 | $45,150,000 | +6.5% | 48,000,000 | 0.0% | 0.02% | +20.0% |
| Q4 2021 | $42,390,000 | -23.4% | 48,000,000 | 0.0% | 0.02% | -28.6% |
| Q3 2021 | $55,363,000 | -1.6% | 48,000,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $56,240,000 | +4.1% | 48,000,000 | 0.0% | 0.02% | -4.5% |
| Q1 2021 | $54,031,000 | – | 48,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 24,587 | $27,677,000 | 2.71% |
| ZAZOVE ASSOCIATES LLC | 15,650,000 | $17,558,000 | 2.07% |
| Mohican Financial Management, LLC | 1,150,000 | $1,279,000 | 0.83% |
| SSI INVESTMENT MANAGEMENT LLC | 4,287,000 | $4,800,000 | 0.35% |
| DeepCurrents Investment Group LLC | 6,918,000 | $7,639,000 | 0.26% |
| Asset Allocation & Management Company, LLC | 240,000 | $269,000 | 0.13% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,362,000 | 0.05% |
| WESTWOOD HOLDINGS GROUP INC | 3,500,000 | $3,968,000 | 0.04% |
| Citadel Advisors | 104,329,000 | $117,539,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,289,000 | 0.03% |